je.st
news
Tag: diabetes
Study: Type 2 diabetes pill Jardiance cuts risk of death
2015-09-17 20:16:48| Biotech - Topix.net
Jardiance sharply reduced chances of dying in diabetic patients at high risk of heart complications, a study shows, making the medication the first shown to lengthen diabetics' lives. The daily pill for Type 2 diabetes reduced deaths from heart complications by 38 percent, deaths from any cause by 32 percent and hospitalizations due to chronic heart failure by 35 percent, according to the study.
Diabetes pill's added bonus is protection from heart attacks
2015-09-17 19:56:49| Food - Topix.net
A diabetes pill called Jardiance cut deaths from heart attacks and strokes in thousands of patients, the first drug to show promise in helping subdue two of the world's most rampant health epidemics. The medicine, sold by Eli Lilly and Boehringer Ingelheim, reduced the risk of heart attacks, strokes and cardiovascular deaths by 14 percent in a study of 7,020 people with adult-onset diabetes and a high risk of heart problems.
Tags: added
heart
protection
bonus
Diabetes pill's added bonus is protection from heart attacks
2015-09-17 19:41:49| Agriculture - Topix.net
A diabetes pill called Jardiance cut deaths from heart attacks and strokes in thousands of patients, the first drug to show promise in helping subdue two of the world's most rampant health epidemics. The medicine, sold by Eli Lilly and Boehringer Ingelheim, reduced the risk of heart attacks, strokes and cardiovascular deaths by 14 percent in a study of 7,020 people with adult-onset diabetes and a high risk of heart problems.
Tags: added
heart
protection
bonus
Merck Provides Diabetes Portfolio Update and Underscores Comprehensive, Long-Term Commitment to Patients with Diabetes
2015-09-17 14:30:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Presents Pivotal Data for Omarigliptin, Mercks Investigational Once-Weekly DPP-4 Inhibitor, and Additional Data from the TECOS CV Safety Trial, at European Association for the Study of Diabetes Annual Meeting KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, provided an update today on its diabetes portfolio and re-affirmed the companys comprehensive, long-term commitment to patients with diabetes. Merck has a proud history in helping patients with type 2 diabetes. Language: English Contact: MerckMedia:Pam Eisele, +1 (267) 305-3558Michael Close, +1 (310) 617-1067orInvestor:Justin Holko, +1 (908) 740-1879Teri Loxam, +1 (908) 740-1986 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: with
update
comprehensive
patients
Merck: Long-acting diabetes pill works same as its Januvia
2015-09-16 21:19:15| Biotech - Topix.net
Drugmaker Merck & Co. says its experimental Type 2 diabetes drug performed about as well as its older daily pill, Januvia, in a late-stage patient test.
Tags: works
diabetes
pill
merck
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] next »